Meet the CO-ADD team across Europe, the US and Australia for the rest of 2018.
One defining moment fundamentally changed the course of Dr Ravina Kullar’s personal and professional life. It was the pivotal moment that led her into specialising in infectious diseases and taking action in the fight against antibiotic resistance, which is projected to kill more than 10 million people worldwide per year by 2050.
CO-ADD's Mark Blaskovich discusses recent 'superbug' news headlines in The Conversation - in English and Indonesian!
Today, the Community for Open Antimicrobial Drug Discovery (CO-ADD) hosted representatives from the Global Antibiotic Research & Development Partnership (GARDP).
CO-ADD team with GARDP represenatives Manica Balasegaram, Jennifer Katz and Paul Field
An antibiotic overlooked since its discovery 40 years ago could help develop new drugs against life-threatening infections caused by some of the world’s most dangerous superbugs.
University of Queensland Institute for Molecular Bioscience (IMB) researchers synthesised the antibiotic, and increased its effectiveness against extensively drug-resistant bacteria, then collaborated with Monash University to evaluate the drug using animal models of infection.
An extra membrane camouflages Gram-negative bacteria from drugs and the immune system.